Elite Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Elite Pharmaceuticals, Inc. (ELTP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$336.14 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$336.14K.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$292.92K.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$292.66K, a 742.92% decline year-over-year.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$234.89K.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.10M.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.95M, a 167.69% decline from fiscal 2015.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $2.88M.
- Elite Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$557.67K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$336.14K 10-Q · filed 2017-08-09 | -$629.06K derived: sum of 2 quarters · filed 2017-08-09 | -$921.72K derived: sum of 3 quarters · filed 2017-08-09 | -$1.16M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2017-03-31 | -$292.92K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | -$585.58K derived: sum of 2 quarters · filed 2017-06-14 | -$820.48K derived: sum of 3 quarters · filed 2017-06-14 | -$1.10M 10-K · filed 2017-06-14 | ||
| 2016-12-31 | -$292.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | -$527.56K derived: sum of 2 quarters · filed 2017-02-09 | -$812.05K 10-Q · filed 2017-02-09 | -$1.38M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-09-30 | -$234.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | -$519.39K 10-Q · filed 2016-11-09 | -$1.09M derived: sum of 3 quarters · filed 2017-08-09 | -$1.04M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-06-30 | -$284.50K 10-Q · filed 2017-08-09 | -$855.32K derived: sum of 2 quarters · filed 2017-08-09 | -$809.80K derived: sum of 3 quarters · filed 2017-08-09 | -$1.52M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | -$570.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | -$525.30K derived: sum of 2 quarters · filed 2017-06-14 | -$1.23M derived: sum of 3 quarters · filed 2017-06-14 | -$1.95M 10-K · filed 2017-06-14 | ||
| 2015-12-31 | $45.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | -$661.66K derived: sum of 2 quarters · filed 2017-02-09 | -$1.38M 10-Q · filed 2017-02-09 | -$1.98M derived: sum of 4 quarters · filed 2017-06-14 | ||
| 2015-09-30 | -$707.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | -$1.42M 10-Q · filed 2016-11-09 | -$2.02M derived: sum of 3 quarters · filed 2017-06-14 | -$2.41M derived: sum of 4 quarters · filed 2017-06-14 | ||
| 2015-06-30 | -$716.34K 10-Q · filed 2016-08-09 | -$1.32M derived: sum of 2 quarters · filed 2017-06-14 | -$1.70M derived: sum of 3 quarters · filed 2017-06-14 | -$2.08M derived: sum of 4 quarters · filed 2017-06-14 | ||
| 2015-03-31 | -$598.83K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | -$983.24K derived: sum of 2 quarters · filed 2017-06-14 | -$1.36M derived: sum of 3 quarters · filed 2017-06-14 | $2.88M 10-K · filed 2017-06-14 | ||
| 2014-12-31 | -$384.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-09 | -$762.17K derived: sum of 2 quarters · filed 2016-02-09 | $3.48M 10-Q · filed 2016-02-09 | $3.41M derived: sum of 4 quarters · filed 2016-06-15 | ||
| 2014-09-30 | -$377.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-30 | $3.86M 10-Q · filed 2015-12-30 | $3.86M 10-Q · filed 2014-11-14 | $3.80M derived: sum of 3 quarters · filed 2016-06-15 | $3.48M derived: sum of 4 quarters · filed 2016-06-15 | |
| 2014-06-30 | $4.24M 10-Q · filed 2015-12-30 | $4.24M 10-Q · filed 2014-08-14 | $4.18M derived: sum of 2 quarters · filed 2016-06-15 | $3.86M derived: sum of 3 quarters · filed 2016-06-15 | $3.82M derived: sum of 4 quarters · filed 2016-06-15 | |
| 2014-03-31 | -$64.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-15 | -$381.29K derived: sum of 2 quarters · filed 2016-06-15 | -$422.78K derived: sum of 3 quarters · filed 2016-06-15 | -$557.67K 10-K · filed 2016-06-15 | ||
| 2013-12-31 | -$316.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | -$358.48K derived: sum of 2 quarters · filed 2015-02-17 | -$493.37K 10-Q · filed 2015-02-17 | |||
| 2013-09-30 | -$41.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-14 | -$176.38K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$134.89K 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | -$191.82K 10-K · filed 2014-06-30 |